In summary, this study identifies key mechanisms by which the RAGE pathway modulates microglial responses during HAHH, suggesting that targeted inhibition of HMGB1–RAGE signaling may attenuate HAHH-associated inflammation and cognitive deficits. This evidence concerns the gene HMGB1 and Cognitive impairment.